Imbeba irwanya SARS-COV-2 NP antibody ya monoclonal
Ibisobanuro birambuye
Amakuru rusange
SARS-CoV-2.Ni karonavirusi ya karindwi izwi kwanduza abantu nyuma ya 229E, NL63, OC43, HKU1, MERS-CoV, na SARS-CoV y'umwimerere.
Ibyiza
| Icyifuzo | CLIA (Gufata-Kumenya): 9-1 ~ 81-4 |
| Isuku | > 95% nkuko byagenwe na SDS-PAGE. |
| Buffer | PBS, pH7.4. |
| Ububiko | Ubike mubihe bidasanzwe kuri -20 ℃ kugeza -80 ℃ umaze kwakira.Kububiko bwigihe kirekire, nyamuneka aliquot uyibike.Irinde gukonjesha inshuro nyinshi. |
Tegeka amakuru
| izina RY'IGICURUZWA | Injangwe.Oya | Indangamuntu ya Clone |
| SARS-COV-2 NP | AB0046-1 | 9-1 |
| AB0046-2 | 81-4 | |
| AB0046-3 | 67-5 | |
| AB0046-4 | 54-7 |
Icyitonderwa: Bioantibody irashobora kugereranya ingano kubyo ukeneye.
Isesengura ryo kugereranya
Imirongo
1.Coronaviridae Itsinda ryiga rya komite mpuzamahanga ishinzwe imisoro ya virusi.Ubwoko bukabije syndrome yubuhumekero bukabije bujyanye na coronavirus: gushyira 2019-nCoV no kuyita SARS-CoV-2.Nat.Microbiol.5, 536–544 (2020)
2.Fehr, AR & Perlman, S. Coronaviruses: incamake yo kwigana kwabo no gutera indwara.Uburyo.Mol.Biol.1282, 1-23 (2015).
3.Shang, J. n'abandi.Ishingiro ryuburyo bwo kumenyekanisha reseptor na SARS-CoV-2.Kamere https://doi.org/10.1038/ s41586-020-2179-y (2020).
Andika ubutumwa bwawe hano hanyuma utwohereze
